RNA from frozen mammary tumour pieces was isolated as previously described
10 (link),68 (link). Cultured cells were lysed (72 h after siRNA transfection in case of human cell lines) in buffer RLY (BIO-52079, Bioline) containing 1% 2-mercaptoethanol. Total RNA extraction and DNase treatment of samples was performed using the
ISOLATE II RNA Mini Kit (BIO-52072, Bioline) according to manufacturer’s guidelines. Purified RNA was quantified using the
DS-11 Series Spectrophotometer/Fluorometer (DeNovix) and subjected to reverse transcriptase reaction using the
Tetro cDNA Synthesis Kit (BIO-65042, Bioline) with oligo (dT)
18 primers (tumour pieces) or random hexamer primers (cells). qPCR was performed using the
SensiFAST SYBR Hi-ROX Kit (BIO-92005, Bioline) and the
QuantStudio 6 Flex Real-Time PCR System (4485691, Thermo Fisher Scientific) operated with the
QuantStudio Real-Time PCR Software (v.1.7.2, Thermo Fisher Scientific). Primers used were designed using Primer-BLAST
69 and a list of which is provided in Supplementary Table
11. Relative quantified cDNA was normalized using either mouse
Hprt (tumour pieces) or
Usf1 (cells) or human
USF1 as the housekeeping transcript.
Zingg D., Bhin J., Yemelyanenko J., Kas S.M., Rolfs F., Lutz C., Lee J.K., Klarenbeek S., Silverman I.M., Annunziato S., Chan C.S., Piersma S.R., Eijkman T., Badoux M., Gogola E., Siteur B., Sprengers J., de Klein B., de Goeij-de Haas R.R., Riedlinger G.M., Ke H., Madison R., Drenth A.P., van der Burg E., Schut E., Henneman L., van Miltenburg M.H., Proost N., Zhen H., Wientjens E., de Bruijn R., de Ruiter J.R., Boon U., de Korte-Grimmerink R., van Gerwen B., Féliz L., Abou-Alfa G.K., Ross J.S., van de Ven M., Rottenberg S., Cuppen E., Chessex A.V., Ali S.M., Burn T.C., Jimenez C.R., Ganesan S., Wessels L.F, & Jonkers J. (2022). Truncated FGFR2 is a clinically actionable oncogene in multiple cancers. Nature, 608(7923), 609-617.